Keerthi Vedantam / dot.LA:
VivoSense, which develops wearable biometric sensors to gather and manage information from sufferers for medical drug trials, raises a $25M Collection A — Because the CEO of Sarepta Therapeutics from 2011 to 2015, Chris Garabedian led a biotech agency striving to search out cures for uncommon illnesses.
[ad_2]
Source link